Lysophosphatidic Acid: A Key Player in Obesity-Crimson Publishers

Lysophosphatidic Acid: A Key Player in Obesity by Hina FB in Intervention in Obesity & Diabetes: Crimson Publishers-Diabetes and Obesity Impact Articles

 In an obese individual, elevated levels of no esterified fatty acids, glycerol, hormones, cytokines, proinflammatory substances, and other substances have been observed. Adipokine, autotoxin (ATX) released by adipocytes exerts a paracrine control over adipogenesis via LPA production which in turn aggravates obesity and insulin resistance in affected individuals. Obesity and its associated disorders (glucose homeostasis and cardiovascular disease like atherosclerosis) show an upregulated expression of ATX- LPA, which makes it a druggable target to treat obesity. In this review we have highlighted the role of lysolipid, LPA and its receptors in obesity and associated anomalies.

https://crimsonpublishers.com/iod/fulltext/IOD.000547.php

For more Open access journals in Crimson Publishers, please click on the link:
https://crimsonpublishers.com/

For more articles in Journal of  Diabetes and Obesity, please click on below link: 
https://crimsonpublishers.com/iod/

Follow On Publons  : https://publons.com/publisher/6342/crimson-publishers
Follow On Linkedin : https://www.linkedin.com/company/crimsonpublishers